Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

• Prif Awduron: Gandhi SK (Awdur), Jensen MM (Awdur), Fox KM (Awdur), Smolen L (Awdur), Olsson AG (Awdur), Paulsson T (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Dove Medical Press, 2012-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Sanjay K Gandhi1, Marie M Jensen2, Kathleen M Fox3, Lee Smolen4, Anders G Olsson5, Thomas Paulsson61AstraZeneca LP, Wilmington, DE, USA; 2AstraZeneca, Lund, Sweden; 3Strategic HealthCare Solution, Monkton, MD; 4Medical Decision Modeling Inc, Indianapolis, IN, USA; 5Department of Medical and Health S...